| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 08/24/2005 | EP1565438A1 Antitumor benzoylsulfonamides |
| 08/24/2005 | EP1565432A1 Histone deacetylase inhibitors |
| 08/24/2005 | EP1565431A1 Cannabinoid receptor ligands |
| 08/24/2005 | EP1565208A1 The use of cytochrome p450 enzyme cyp2wi as a drug traget for cancer therapy |
| 08/24/2005 | EP1565199A2 Therapeutic polypeptides,nucleic acids encoding same, and methods of use |
| 08/24/2005 | EP1565196A1 Clinical application of dendritic cell-based cancer immunotherapy |
| 08/24/2005 | EP1565195A1 Anticancer or antiviral composition |
| 08/24/2005 | EP1565193A2 Methods and compositions for treating cancer using proteasome inhibitors |
| 08/24/2005 | EP1565192A2 Method and compositions for temporarily incapaciting subjets |
| 08/24/2005 | EP1565187A2 Methods of treating cancer and related methods |
| 08/24/2005 | EP1565178A2 Method and compositions for treating persistent pulmonary hypertension using aralkyl ester soft drugs |
| 08/24/2005 | EP1565176A1 Agent having a destructive effect on malignant tumors and method for the production thereof |
| 08/24/2005 | EP1504019B1 Platinum complexes having antitumor activity |
| 08/24/2005 | EP1458713B1 Indolinone derivatives useful as protein kinase inhibitors |
| 08/24/2005 | EP1392307B1 Tartrate salts of 5,8,14-triazatetracyclo[10.3.1.02,11.04,9]-hexadeca-2(11),3,5,7,9-pentaene |
| 08/24/2005 | EP1360185B1 Carboline derivatives |
| 08/24/2005 | EP1353927B1 Sulfamidothienopyrimidines and the use of the same as phosphodiesterase v inhibitors |
| 08/24/2005 | EP1353912B1 2-arylimino-2,3-dihydrothiazole derivatives, methods for preparing them and therapeutic use thereof |
| 08/24/2005 | EP1343789B1 Tricyclic derivatives of indole with antiangiogenic activity |
| 08/24/2005 | EP1335917B1 Condensed pyridoindole derivatives |
| 08/24/2005 | EP1317413B1 Substituted biphenyl derivatives, method for preparing same and pharmaceutical compositions containing same |
| 08/24/2005 | EP1272505B1 8beta-substituted-11beta-pentyl- and 11beta-hexyl-estra-1,3,5(10)-triene derivatives |
| 08/24/2005 | EP1246919B1 Progenitor cell preservation factors and related methods and products |
| 08/24/2005 | EP1244652B1 2-(1h-indol-3-yl)-2-oxo-acetamides with antitumor activity |
| 08/24/2005 | EP1216246B1 N-substituted 4-aminopteridines, synthesis and use thereof as pharmaceutical agent |
| 08/24/2005 | EP1214304B1 Benzylidene-thiazolidinediones and analogues and their use in the treatment of diabetes |
| 08/24/2005 | EP1169025B1 Transdermal drug delivery devices comprising a polyurethane drug reservoir |
| 08/24/2005 | EP1144394B1 1-heterocycle substituted diarylamines |
| 08/24/2005 | EP1131301B1 2-phenylbenzimidazoles and 2-phenylindoles, and production and use thereof |
| 08/24/2005 | EP1124804B1 Prostaglandin endoperoxide h synthase biosynthesis inhibitors |
| 08/24/2005 | EP0914102B1 Compositions and methods for treating or preventing diseases of body passageways |
| 08/24/2005 | EP0684955B1 Nuclear matrix proteins |
| 08/24/2005 | EP0662132B1 Self-assembling recombinant hpv16 papillomavirus capsid proteins |
| 08/24/2005 | CN1659288A Method to inhibit cell growth using oligonucleotides |
| 08/24/2005 | CN1659284A Improved chimeric glycoproteins and pseudotyped lentiviral vectors |
| 08/24/2005 | CN1659180A Novel recombinant anticoagulant proteins |
| 08/24/2005 | CN1659171A Specific cyclolignans for treating insulin-like growth factor-1 receptor dependent diseases |
| 08/24/2005 | CN1659165A Quinolinone derivatives |
| 08/24/2005 | CN1659163A Substituted thiophenes: compositions, processes of making, and uses in disease treatment and diagnosis |
| 08/24/2005 | CN1659162A Tricyclic thrombin receptor antagonists |
| 08/24/2005 | CN1659157A Terphenyl derivatives, preparation thereof, compositions containing same |
| 08/24/2005 | CN1659148A Aryloximes |
| 08/24/2005 | CN1659147A Pyridazine derivatives |
| 08/24/2005 | CN1659145A 3-cyanoquinolines as inhibitors of EGF-R and HER2 kinases |
| 08/24/2005 | CN1659144A Quinoline and isoquinoline derivatives, a process for their production and their use as inflammation inhibitors |
| 08/24/2005 | CN1659139A Fluorinated cycloalkyl-derivatized benzoylguanidines, process for their preparation, their uses as medicament |
| 08/24/2005 | CN1659136A Novel sodium channel blockers |
| 08/24/2005 | CN1659130A Induction of apoptosis in cancer cells |
| 08/24/2005 | CN1658924A Method of treating biological materials with translating electrical fields and electrode polarity reversal |
| 08/24/2005 | CN1658905A Modified byrodin 1 with reduced immunogenicity |
| 08/24/2005 | CN1658904A Combinations comprising epothilones and pharmaceutical uses thereof |
| 08/24/2005 | CN1658902A Thermosensitive polymer carriers having a modifiable physical structure for biochemical analysis, diagnosis and therapy |
| 08/24/2005 | CN1658899A Modified CEA nucleic acid and expression vectors |
| 08/24/2005 | CN1658896A Use of compounds having the biological activity of vasoactive intestinal peptide for the treatment of sarcoidosis |
| 08/24/2005 | CN1658890A Preparation extracted from stephania tetrandra S. Moor and the use thereof |
| 08/24/2005 | CN1658887A Novel solid preparation containing block copolymer and anthracycline anticancer agent and process for producing the same |
| 08/24/2005 | CN1658886A Hormone replacement therapy |
| 08/24/2005 | CN1658885A Hormone replacement therapy |
| 08/24/2005 | CN1658880A Combination therapy for the treatment of cancer |
| 08/24/2005 | CN1658877A Basic non-peptide bradykinin antagonists and pharmaceutical compositions therefrom |
| 08/24/2005 | CN1658869A N- ((3-oxo2, 3-dihydro-1H-isoindol-1-yl) acetyl) guanidine derivatives as NHE-1 inhibitors for the treatment of infarction and angina pectoris |
| 08/24/2005 | CN1658866A Tri-substituted heteroaryls and methods of making and using the same |
| 08/24/2005 | CN1658865A Hepatoprotective activity of 10-o-p-hydroxybenzoyiaucubin |
| 08/24/2005 | CN1658863A Severe sepsis preventive therapeutic agent |
| 08/24/2005 | CN1658860A Method of inhibiting angiogenesis |
| 08/24/2005 | CN1658856A Therapeutic agent for cancer |
| 08/24/2005 | CN1658848A Methods for identification of modulators of angiogenesis, compounds discovered thereby, and methods of treatment using the compounds |
| 08/24/2005 | CN1658845A Stealth lipid nanocapsules, methods for the preparation thereof, and use thereof as a carrier for active principle(s) |
| 08/24/2005 | CN1657633A Recombined adenovirus carrying wide-type PTEN gene and its preparation method and use |
| 08/24/2005 | CN1657632A Combination adeno-associated virus of expression human CYP2J2 antigene and its preparation method |
| 08/24/2005 | CN1657618A Hepatic correlative oncogene inhibitory and use |
| 08/24/2005 | CN1657542A Marine fungi polysaccharide and its extraction method and use |
| 08/24/2005 | CN1657537A Central body located gene and its use in medicinal region |
| 08/24/2005 | CN1657534A Penthorum seponin (PCPTS) and its antihepatitis and antimutation aetion |
| 08/24/2005 | CN1657100A Nano-class preparation for selective target stomach cancer-and lymph system and its preparation method |
| 08/24/2005 | CN1657099A Preparation method of ultra paramagnetic particle iodized oil suspension |
| 08/24/2005 | CN1657090A Extract of prinsepia wood and its bioactivity function |
| 08/24/2005 | CN1657049A Cyclophosphamide compound preparation coataining glycyrrhizin |
| 08/24/2005 | CN1657048A Laminaran granule and its preparation technology |
| 08/24/2005 | CN1657047A Formula of calebassine dripping pills and its preparation method |
| 08/24/2005 | CN1657040A Curcumin and phosphatide composite and its preparation method |
| 08/24/2005 | CN1216056C Sulfamato hydroxamic acid metalloprotease inhibitor |
| 08/24/2005 | CN1216051C Macrocyclic analogs and method of their use and preparation |
| 08/24/2005 | CN1216047C Tricyclic lactam and sultam derivatives and their use as histone deacetylase inhibitors |
| 08/24/2005 | CN1215877C Recombined human interleukin-2 injection and preparing method thereof |
| 08/24/2005 | CN1215862C Traditional Chinese decoction liquid for treating malignant tumor and preparation method |
| 08/24/2005 | CN1215849C Method for preparing baicalin liquid |
| 08/23/2005 | US6934639 Using the three-dimensional structure of human collagenase-3 (MMP-13), a member of the matrix metalloproteinase (MMP) for drug design of MMP-13 inhibitors |
| 08/23/2005 | US6933373 Tumor suppressor protein for as a antiproliferative agent |
| 08/23/2005 | US6933321 For therapy of androgen-dependent diseases such as prostate cancer, benign prostatic hyperplasia, precicious puberty, polycystic ovarian syndrome, acne, hirsutism, seborrhea, androgenic alopecia and premature male baldness |
| 08/23/2005 | US6933320 Combination comprising combretastatin and anticancer agents |
| 08/23/2005 | US6933315 bis indole derivatives containing acetylated saccharide groups |
| 08/23/2005 | US6933306 Anticancer agents; antiinflammatory agents; autoimmune disease |
| 08/23/2005 | US6933305 Amide compounds and use thereof |
| 08/23/2005 | US6933304 Antitumor agents, osteoporosis |
| 08/23/2005 | US6933303 Antidiabetic agents |
| 08/23/2005 | US6933295 Substituted isoindoles and the use thereof |
| 08/23/2005 | US6933290 2-{N-(2-amino-3-(heteroaryl or aryl)propionyl)-aminoacyl}-amino}-alkylboronic acid derivatives |
| 08/23/2005 | US6933271 Aimed at neoplastic cells with gonadotropin releasing hormone binding sites; anticarcinogenic agents; genetically engineered Pseudomonas Exotoxin |
| 08/23/2005 | US6933129 Method for culturing and assaying cells |